Comment

NCPDP Comment

  1. NCPDP recommends that ONC remove the comment, “The NCPDP WG18 Patient Consent task group is working on a solution for the exchange of patient consent information between providers,” from the Limitations, Dependencies, and Preconditions for Consideration section. The WG18 Patient Consent Task Group has been disbanded.
  2. NCPDP recommends that ONC create a new distinct category from the existing electronic consent for patient preference. The goal of the new category is to obtain authorization for an individual medication and not to designate a preference for other medications.
  3. NCPDP recommends that ONC add the following category:
    1. Category Name: Obtaining patient or provider authorization/consent related to a specific medication fulfillment
      Type: Implementation Specification
      Standard: Specialty Medication Enrollment FHIR® Implementation Guide STU2
      Standards Process Maturity: Final
      Implementation Maturity: Pilot

                   Adoption Level: 1
                   Federally Required: No
                   Cost: Free
                   Test Tool Availability: No

Pharmacy HIT Collaborative (PHIT) comment

PHIT supports NCPDP’s recommendation to create a new distinct category from the existing electronic consent for patient preference: Obtaining patient or provider authorization/consent related to a specific medication fulfillment. As NCPDP notes, the goal of the new category is to obtain authorization from an individual medication and not to designate a preference for other medications.

NCPDP Comments

The NCPDP WG18 Patient Consent task group is working on a solution for the exchange of patient consent information between providers.

NCPDP Comment

The NCPDP WG18 Patient Consent task group is working on a solution for the exchange of patient consent information between providers.

NCPDP Comment

  1. NCPDP is forming a task group to explore the need for transactions that support the exchange of patient consent.